When you’re living with metastatic bladder cancer, it can be hard to see past the lab workups, routine scans, and treatment plans. But it’s important that you — your goals, your hobbies, your daily ...

There’s a lot to juggle and process after receiving a metastatic bladder cancer diagnosis — follow-up tests, medical appointments, treatment regimens. All of it can feel overwhelming at times, adding ...

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder cancer treatment decisions. At the 2026 NCCN Annual Conference, Dr. Thomas ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...

Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease stage and type. Strategies for the treatment of bladder cancer may vary by ...

Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder cancer ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

Perioperative Keytruda-Padcev for MIBC approved regardless of cisplatin eligibility ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial. Recent ...

In late June 2026, Merck reported multiple oncology milestones, including U.S. FDA approval of KEYTRUDA and KEYTRUDA QLEX ...

Not long ago, I saw a patient whose disease was, by all clinical measures, under control. Her cystoscopy was clear. She was completing therapy as planned. There were no complications that would raise ...